Oxolife

Investments | Biotech

The biotech company, Oxolife, raises 5 million euros for its Phase II Clinical Trial

Oxolife, created to develop a new treatment to improve the female fertility rate, completed its first funding round by raising 5,000,000 euros in an investment led by Inveready Asset Management and the public body CDTI.

This website uses cookies

This Website uses site management and analytics cookies you can further check our cookies policy here and read here how we process your data and how to exercise your rights.
Accept Read More

The below list details the cookies used in our website.

Cookie	Type	Duration	Description
__cfduid	third party	1 year	Used by the contentn etwork, Cloudflare, to identify trusted web traffic.
_ga	third party	2 years	Registers a uniqu e ID that is used to generate statistical data on how the visitor uses the website.
woocommerce_cart_hash	session	session	e-Commerce temporary session
woocommerce_items_in_cart	session	session	e-Commerce temporary session
wp_woocommerce_session_	session	session	e-Commerce temporary session